Please select the option that best describes you:

Is there any evidence regarding bone density gains/fracture reduction in the setting of treatment with romosozumab after a two year course of teriparatide?   

Many patients are interested in romosozumab for "maximizing bone gain" and preventing future fractures. Some have had anabolic therapy with teriparatide. Is there any data supporting this approach in patients who remain high risk for fragility fractures?

Answer from: at Academic Institution